首页> 美国卫生研究院文献>Internal Medicine >Efficacy of Oral Factor Xa Inhibitor for Venous Thromboembolism in a Patient with Antithrombin Deficiency
【2h】

Efficacy of Oral Factor Xa Inhibitor for Venous Thromboembolism in a Patient with Antithrombin Deficiency

机译:口服因子Xa抑制剂对抗凝血酶缺乏症患者静脉血栓栓塞的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 19-year-old man was referred due to sudden onset of right foot pain and chest discomfort. Contrast-enhanced computed tomography revealed massive thrombi in the right pulmonary artery and femoral vein. The patient's father had experienced multiple recurrences of venous thromboembolism (VTE) and was diagnosed with inherited antithrombin deficiency by a genetic examination. The patient was administered the oral factor Xa inhibitor rivaroxaban (30 mg). After seven days, the thrombus disappeared. Rivaroxaban (15 mg) was continued for 6 months with no recurrence, indicating the efficacy of this factor Xa inhibitor for the treatment and prevention of VTE in patients with antithrombin deficiency.
机译:由于右脚疼痛突然发作和胸部不适,转诊了一名19岁男子。对比增强的计算机断层扫描显示右肺动脉和股静脉中有大量血栓。患者的父亲经历了多次静脉血栓栓塞(VTE)复发,并通过基因检查被诊断为遗传性抗凝血酶缺乏症。给予患者口服Xa因子抑制剂利伐沙班(30毫克)。七天后,血栓消失了。利伐沙班(15 mg)持续6个月没有复发,表明该Xa因子抑制剂在抗凝血酶缺乏症患者中治疗和预防VTE的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号